SQXlogo
  • My Dashboard
  • Bond Academy
  • Tools
    • Bond Screener
    • Issuer Directory
    • Portfolio Builder
    • Discussion Board
  • Data Partners
‌
‌
  • Home
  • My Dashboard
  • Bond Academy
  • Tools
  • Data Partners
  • LoginCreate a free account
SQX-logo
SQX-white-logo© SQX BONDS. All rights reserved | Privacy Policy | Terms and Conditions | Represent a financial institution? | Customer Support
Visit SQXBonds on linkedinVisit SQXBonds on LinkedInVisit SQXBonds on facebookVisit SQXBonds on LinkedInVisit SQXBonds on instagramVisit SQXBonds on LinkedInVisit SQXBonds on twitterVisit SQXBonds on LinkedInVisit SQXBonds on iplVisit SQXBonds on LinkedIn
←Back

H Lundbeck bond | 0.88% 2027-10-14 EUR | XS2243299463

Change % : ▼-0.002%

View all data FOR FREE!

Create an account today, no credit card required.

Overview

pricing as of 2026-04-27
3.21
0.875
96.713
2027-10-14
EUR
97.255/95.132

Analytics

1.408
1.453
2.121
‌
‌
‌
‌

Bond Information

Issue Type
XXXX
Country
Denmark
Industry
XXXX
Region
XXXX
Maturity Date
2027-10-14
Par Value
100000
Callable
XXXX
Next Call Date
XXXX
Call Type
XXXX
Call Price (%)
XXXX
Series
XXXX
Class
XXXX
Maturity Structure
XXXX
Amount Outstanding (mil)
500.00

Coupon Information

Coupon
0.875
Coupon Type
XXXX
Coupon Frequency
XXXX
First Coupon Date
XXXX
Last Coupon Date
XXXX

Risk Information

Sinking Fund
XXXX
Security
XXXX
Subordination
XXXX
Debt Type
XXXX

Issuance Information

Issue Date
XXXX
Dated Date
XXXX
Issue Size (mil)
500.000
Min. Piece
XXXX
Min. Increment
XXXX

About the LUNDC 0.88% 2027-10-14 EUR bond (XS2243299463)

This H. Lundbeck AS corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million EUR and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020.

More bonds from H. Lundbeck AS

LUNDC 3.38% 2029-06-02 EUR

XS3081808837

Pays a 3.375% coupon and matures on June 02, 2029.

99.65 EUR▼ -0.02

About the issuer H. Lundbeck AS

H. Lundbeck AS, founded in 1915 and headquartered in Valby, Denmark, is a global pharmaceutical company dedicated to developing innovative treatments for brain disorders. The company specializes in therapies for psychiatric and neurological conditions, with key products including antidepressants and antipsychotic medications.